The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
CTMC, Invectys, and MD Anderson announce strategic collaboration for CAR T cell therapy development
HOUSTON – Invectys, Inc., the University of Texas MD Anderson Cancer Center, and the Cell Therapy Manufacturing Center (CTMC), a joint venture...
Recent News
Emerging Treatments for Cancer e-book
Access article: BioPharm International
TILs’ Tomorrow Bringing More Cancers Under Immune Control
Four leading companies prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities...
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies.
Preferred Partner Network (PPN) members will become Centers of Excellence for the IRO® platform combining best-in-class technology with...
Emerging Therapies in Oncology: Tumor-Infiltrating Lymphocytes
Author(s): Susan Haigney BioPharm International® spoke with Jason Bock, founder and CEO of CTMC, to find out about the newest cancer treatments,...
2025 pharma predictions
From manufacturing to supply chain strategies, here’s how drug manufacturers are looking at the year ahead. Andrea Corona access article: Pharma...
Patient-focused manufacturing models for personalised therapies
Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, CTMC, is challenging the...
New cell therapy model accelerates cancer treatment development
Article Link: https://www.drugtargetreview.com/article/155900/new-cell-therapy-model-accelerates-cancer-treatment-development/
2025 cell and gene challenges: Scalability, supply chain and manufacturing
Article Link:...
Scrip Asks… What Does 2025 Hold For Biopharma? Part 2: Funding, M&A And Partnering
Article Link:...